Home › Funds › ALGEBRIS (UK) LTD › PCGPRX
ALGEBRIS (UK) LTD position in PCGPRX
PG&E CORP
ALGEBRIS (UK) LTD reported holding 365,000 shares of PCGPRX (PG&E CORP) in its Q3 2026 13F filing — a position valued at US$11.3M, representing 0.63% of its reported portfolio and ranking #40 among its reported holdings. ALGEBRIS (UK) LTD has disclosed PCGPRX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ALGEBRIS (UK) LTD's PCGPRX position evolved
ALGEBRIS (UK) LTD first disclosed a stake in PCGPRX in Q4 2024 at 505,000 shares (US$24.3M). The position peaked in Q1 2025 at 665,000 shares, worth US$27.5M. Across 8 filings, ALGEBRIS (UK) LTD increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 365,000 shares valued at US$11.3M. Notable position changes include a 32% increase in Q1 2025, a 45% trim in Q2 2025.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 505.00K | $24.28M | New |
| Q1 2025 | 665.00K | $27.54M | Add |
| Q2 2025 | 365.00K | $13.70M | Reduce |
| Q3 2025 | 365.00K | $14.36M | Hold |
| Q4 2025 | 365.00K | $14.83M | Hold |
| Q1 2026 | 365.00K | $15.52M | Hold |
| Q2 2026 | 365.00K | $14.92M | Hold |
| Q3 2026 | 365.00K | $11.26M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PCGPRX and 13F data
PCGPRX (PG&E CORP) is a company whose sector is not yet classified in our data. 40 other funds we track also report a position in PCGPRX — the largest reported positions include Aequim Alternative Investments LP (US$78.0M), CREDIT INDUSTRIEL ET COMMERCIAL (US$55.0M), Sculptor Capital LP (US$46.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PCGPRX
- Aequim Alternative Investments LP 2.50M sh · $78.05M · Q3 2026
- CREDIT INDUSTRIEL ET COMMERCIAL 1.75M sh · $55.04M · Q3 2026
- Sculptor Capital LP 1.12M sh · $46.45M · Q2 2026
- TPG GP A, LLC 680.00K sh · $28.17M · Q2 2026
- WOLVERINE ASSET MANAGEMENT LLC 705.35K sh · $22.31M · Q3 2026
- Benefit Street Partners LLC 333.26K sh · $13.79M · Q2 2026
- Portman Square Capital LLP 381.00K sh · $12.05M · Q3 2026
- STANSBERRY ASSET MANAGEMENT, LLC 269.38K sh · $11.14M · Q2 2026
- Skaana Management L.P. 236.47K sh · $7.38M · Q3 2026
- BlueCrest Capital Management Ltd 207.60K sh · $6.48M · Q3 2026
- SUSQUEHANNA ADVISORS GROUP, INC. 150.00K sh · $6.21M · Q2 2026
More on ALGEBRIS (UK) LTD
FAQ
How long has ALGEBRIS (UK) LTD held PCGPRX?
ALGEBRIS (UK) LTD has disclosed PCGPRX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is ALGEBRIS (UK) LTD's current position in PCGPRX?
As of Q3 2026, ALGEBRIS (UK) LTD holds 365.00K shares of PCGPRX (PG&E CORP), valued at $11.26M, representing 0.63% of its reported portfolio and ranking #40.
Has ALGEBRIS (UK) LTD been buying or selling PCGPRX?
In the latest 13F filing (Q3 2026), ALGEBRIS (UK) LTD held unchanged its position in PCGPRX. The position peaked in Q1 2025 at 665.00K shares.
Which other funds hold PCGPRX?
Other major institutional holders of PCGPRX include Aequim Alternative Investments LP, CREDIT INDUSTRIEL ET COMMERCIAL, Sculptor Capital LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.